Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24665 | 0.82 | — | — | |
| Pyridine SCHEMBL9214710 | 0.78 | TSHR (0.60) | TSHR | |
| Benzene SCHEMBL28732344 | 0.76 | TP53 (0.43) | TP53TSHR | |
| Benzene SCHEMBL5665687 | 0.76 | TP53 (0.43) | TP53TSHR | |
| Benzene SCHEMBL29418269 | 0.76 | TP53 (0.43) | TP53TSHR | |
| Benzene SCHEMBL11904791 | 0.76 | TP53 (0.43) | TP53TSHR | |
| Benzene SCHEMBL18274779 | 0.76 | TP53 (0.43) | TP53TSHR | |
| Benzene SCHEMBL10623824 | 0.76 | TP53 (0.43) | TP53TSHR | |
| Ethylene SCHEMBL28663109 | 0.71 | — | — | |
| Benzene SCHEMBL9099545 | 0.71 | TP53 (0.38) | TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102153507-B | Preparation method of 2,3-dichloropyridine | LIANHE CHEMICAL TECHNOLOGY CO LTD | 2012-11-21 | — | — | CN | disclosed |
| US-8293918-B2 | Process for producing dihalopyridines | JUBILANT ORGANOSYS LIMITED (IN) | 2012-10-23 | — | — | US | disclosed |
| CN-102153507-A | Preparation method of 2,3-dichloropyridine | LIANHE CHEMICAL TECHNOLOGY CO LTD | 2011-08-17 | — | — | CN | disclosed |
| CN-101774966-A | Process for producing dihalopyridines | JUBILANT ORGANOSYS LTD | 2010-07-14 | — | — | CN | disclosed |
| US-20100160641-A1 | PROCESS FOR PRODUCING DIHALOPYRIDINES | JUBILANT ORGANOSYS LTD. (IN) | 2010-06-24 | — | — | US | disclosed |
| US-20070004937-A1 | METHODS FOR THE PREPARATION OF PHOSPHONIC ACID DERIVATIVES | FERRO CORPORATION (US) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160641-A1 | PROCESS FOR PRODUCING DIHALOPYRIDINES | QDPR, HDHD5, DDT | TP53 3118/4885TSHR 3928/4885 |
| US-20070004937-A1 | METHODS FOR THE PREPARATION OF PHOSPHONIC ACID DERIVATIVES | PDXK, PPA1, P2RY6 | TP53 3849/4885TSHR 2771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.